Explore evidence

27 %The prevalence of fever due to malaria after travelling to a tropical country ranges from 27% to 52%.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

0 samplesNone of the 101 genotyped samples had the Pfdhfr I164L mutation.

Burkina Fasopaludismeobserved 2010published 2017Malaria journaleurope_pmcdocument of 10 observations

54.2 %In 376 of 694 (54.2%) included children, malaria was microscopically confirmed.

Burkina Fasopaludismepublished 2014Malaria journaleurope_pmcdocument of 3 observations

20 %Among 742 enrolled COVID-19 patients with valid malaria tests in western Kenya and Burkina Faso, 151 (20%) had Plasmodium falciparum malaria co-infection.

Burkina FasoCOVID-19 · paludismeobserved between Jan 8, 2021 and Jan 24, 2022published 2026The Lancet. Global healthPubMeddocument of 8 observations

An. gambiae s.l. was resistant to DDT and cross-resistant to pyrethroids at the two sites.

Burkina Fasopaludismeobserved 2008published 2012Parasites & vectorseurope_pmcdocument of 5 observationsDOI 10.1186/1756-3305-5-127

0.751 Pearson_rThere is a positive correlation between anti-major repeat IgG and full-length anti-PfCSP4/38 IgG at D180 (r = 0.7514, P = 0.0001).

Burkina FasopaludismeHAL · Unilimdocument of 39 observations

15 %In the dry season, 213 out of 1,382 patients without fever (15%) had a Plasmodium falciparum infection in Burkina Faso.

Burkina Fasopaludismeobserved dry seasonpublished 2010Malaria journaleurope_pmcdocument of 20 observationsDOI 10.1186/1475-2875-9-192

1.8 %Au Burkina Faso, l'examen microscopique a détecté une prévalence de 1,8 % d'infections à P. ovale chez 830 enfants âgés de trois à quinze ans.

Burkina FasopaludismeHAL · Unilimdocument of 80 observations

4,116 childrenAmong the 4,116 children (6-59 months old) enrolled and followed up for 28 days post treatment, a total of 6,238 adverse events were reported.

Burkina Fasopaludismepublished 2014PloS oneeurope_pmcdocument of 4 observationsDOI 10.1371/journal.pone.0096388

4 %HepB IgG pool showed 4% inhibition of parasite liver burden compared to naïve controls in the transgenic sporozoite challenge model.

Burkina FasopaludismeHAL · Unilimdocument of 39 observations

50 %During the rainy season, around 50% of patients had a new malaria episode by Day 28.

Burkina Fasopaludismepublished 2017Annals of parasitologyeurope_pmcdocument of 4 observations

14.3 titerAt day 180, the PfCSP-specific geometric mean titer (GMT) was 14.3 in the ProC6C-AlOH group.

Burkina Fasopaludismeobserved D180HAL · Unilimdocument of 39 observations

High prevalence of insecticide resistance was detected in Vallée du Kou (VK) to pyrethroids, DDT, and dieldrin.

Burkina Fasopaludismepublished 2013Geneeurope_pmcdocument of 6 observations

5.28 mosquitoes_per_house_per_nightIn Gaoua, the mean nightly Anopheles density dropped from 5.28 mosquitoes/house/night in year 1 to 1.43 in year 2 and rebounded to 2.75 in year 3.

Burkina FasopaludismeHAL · Unilimdocument of 87 observations

10 %The prevalence of congenital malaria by qPCR increased to 10% among newborns from mothers infected at delivery in the Nanoro health district, Burkina Faso.

Burkina Fasopaludismepublished 2017Scientific reportseurope_pmcdocument of 2 observationsDOI 10.1038/s41598-017-02173-6

5 signalsA review of the manufacturer package leaflets, an online Multi-Drug Symptom/Interaction Checker (DoubleCheckMD) and further by therapeutic area experts reduced the number of signals to five.

Burkina Fasopaludismepublished 2014PloS oneeurope_pmcdocument of 4 observationsDOI 10.1371/journal.pone.0096388

86.56 %In the town of Koudougou, 86.56% of respondents reported a low risk of malaria contamination when living more than 500m from waste.

Burkina FasopaludismeHAL · Unilimdocument of 110 observations

4.85 minutesAnopheles gambiae stopped swarming 4 minutes and 51 seconds earlier than Anopheles coluzzii.

Burkina Fasopaludismepublished 2013Parasites & vectorseurope_pmcdocument of 7 observationsDOI 10.1186/1756-3305-6-275

34.8 %Vaccine efficacy of RTS,S/AS01 against severe malaria in the combined age categories was 34.8% in the per-protocol population during an average follow-up of 11 months.

Burkina Fasopaludismepublished 2011The New England journal of medicineeurope_pmcdocument of 7 observationsDOI 10.1056/nejmoa1102287

98.5 %In children who received RTS,S/AS01E vaccine in Burkina Faso and Mali, 98.5% showed a 10-fold increase in anti-CSP IgG antibody titres post-2017 as measured by GSK ELISA.

Burkina Faso · Malipaludismeobserved post-2017HAL · Unilimdocument of 105 observations

70 %In two populations from Burkina Faso (2007–2008), hemoglobin S heterozygosity (AS) was associated with a 70% reduction in harboring Plasmodium falciparum parasitemia compared to hemoglobin AA.

Burkina Fasopaludismeobserved 2007-2008published 2015The Journal of infectious diseaseseurope_pmcdocument of 3 observations

2.8 %In Nanoro, Burkina Faso, the VAGKGS haplotype was present in 2.8% of samples in 2020.

Burkina Fasopaludismeobserved 2020published 2024Scientific reportsPubMeddocument of 4 observations

1.4 %Malaria prevalence among febrile adults from non-malaria endemic countries travelling or living in Burkina Faso was 1.4% for journeys under 3 months with adapted and well-taken chemoprophylaxis.

Burkina FasopaludismeHAL · Unilimdocument of 83 observations

20 %The proportion of chloroquine-resistant Plasmodium falciparum isolates was 20% in 1995 in the region of Bobo-Dioulasso.

Burkina Fasopaludismeobserved 1995published 1998Tropical medicine & international health : TM & IHeurope_pmcdocument of 4 observations

The survey was conducted from June to November 2023, a period of high endemicity of malaria.

Burkina Fasopaludismeobserved June to November 2023HAL · Unilimdocument of 110 observations